Research Article

Factors Influencing Blood Concentration of Voriconazole and Therapeutic Drug Monitoring in Patients with Child–Pugh Class C Cirrhosis

Figure 2

Distribution of voriconazole trough plasma concentrations (Cmin) in two maintenance dose regimens.
(a)
(b)